Issue Brief

Should transgender Americans be allowed to serve in the U.S. military?

A question that has shifted with each of the last four administrations is again before the federal courts.

Political News 5 min read Updated Jun 2026
The issue in plain English
Should transgender Americans be allowed to serve in the U.S. military?

U.S. policy on transgender military service has reversed four times since 2016, and recent court rulings have allowed new restrictions to take effect while litigation proceeds. Supporters of open service emphasize individual fitness and recruiting needs; opponents cite medical readiness, costs and unit cohesion.

Why this matters
What the answer actually changes.
Policy outcomes

How this issue is resolved shapes the rules voters live under.

Representation

The arguments reveal who gets a stronger voice when the question is settled.

Trust

Whether the process feels fair influences how voters trust the outcome.

The arguments
Two sides of the debate.
The goal is not to decide for the voter. It is to make the strongest competing views easy to understand.
Supporters say
The case for allowing open service

Proponents argue that military eligibility should turn on whether an individual can meet the physical, mental and conduct standards required of all service members, not on gender identity. They point to the 2016 RAND analysis, which concluded that the projected costs of transition-related care and any effects on readiness would be small relative to the overall force, and to the experience of allied militaries that permit open service. Supporters also note that the armed forces have repeatedly missed recruiting goals in recent years and contend that excluding otherwise qualified volunteers narrows the talent pool. Civil liberties groups add that troops already serving have met every standard asked of them, and that abrupt policy reversals can disrupt units and undermine retention.

Critics say
The case for restrictions

Opponents of open service argue that gender dysphoria and related medical treatment can affect deployability, because service members undergoing surgery or hormone therapy may be non-deployable for extended periods and may require ongoing care in austere environments. They contend that uniform medical and physical standards, rather than individualized accommodations, best preserve readiness and unit cohesion. Supporters of the restrictions also frame the issue as one of military judgment and executive authority, arguing that the commander in chief and the Pentagon — not the courts — should set personnel standards. They cite the Supreme Court's 2025 decision allowing the policy to take effect as recognition that such judgments fall within the executive branch's traditional discretion over military affairs.

Key facts
Numbers behind the question.
1,320–6,630
Estimated transgender active-duty service members

RAND Corporation, 2016

4
Times the policy has changed since 2016 (Obama, Trump, Biden, Trump)
June 1, 2026
Appeals court allowed enlistment ban; blocked discharges pending litigation
2025
Supreme Court allowed Trump administration policy to take effect during challenges
Context
A decade of shifting policy

The Obama administration ended the ban on open transgender military service in 2016, citing a Defense Department-commissioned RAND Corporation study that estimated between 1,320 and 6,630 transgender troops were then serving on active duty out of roughly 1.3 million. In 2017, the first Trump administration moved to restrict service; the Biden administration reversed those restrictions in 2021; and in 2025 the second Trump administration reinstated them. The current policy is being litigated in federal court. The Supreme Court in 2025 allowed the administration's restrictions to take effect during the legal challenges, and on June 1, 2026, a federal appeals court permitted the government to bar transgender people from enlisting while blocking the discharge of current transgender service members pending further proceedings.

Evidence
What the data show — and don't

The most frequently cited estimate of transgender service remains the 2016 RAND study, which projected 1,320 to 6,630 transgender troops on active duty and estimated transition-related health care would increase active-component medical costs by roughly 0.04 to 0.13 percent. RAND found little evidence from foreign militaries that open service measurably harmed readiness or cohesion. Other analyses, including those cited by the Defense Department in 2018 and 2025, have emphasized non-deployability rates and questioned how widely the foreign comparisons apply. Independent, post-2021 U.S. data on deployability, retention and unit performance among transgender troops remain limited, and both sides draw on the same underlying numbers to reach different conclusions.

Continue exploring
Keep going.